Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Clinical and Translational Medicine|October 17, 2022
Single-cell transcriptome profiling reveals the key role of ZNF683 in natural killer cell exhaustion in multiple myelomaXin Li, Mengping Chen, Yike Wan, et al.
Cell & Bioscience|January 31, 2023
Dynamic single-cell RNA-seq analysis reveals distinct tumor program associated with microenvironmental remodeling and drug sensitivity in multiple myelomaMengping Chen, Yike Wan, Xin Li, et al.
Cancer Letters|April 13, 2023
Single-cell RNA sequencing reveals XBP1-SLC38A2 axis as a metabolic regulator in cytotoxic T lymphocytes in multiple myelomaYike Wan, Mengping Chen, Xin Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 31, 2024
An animal model recapitulates human hepatic diseases associated with GATA6 mutationsWenpeng Shi, Xiaogui Yi, Hua Ruan, et al.
Blood|March 21, 2007
The zebrafish udu gene encodes a novel nuclear factor and is essential for primitive erythroid cell developmentYanmei Liu, Linsen Du, Motomi Osato, et al.
Annals of Hematology|September 3, 2024
Daratumumab, bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone alone in transplant-ineligible Asian patients with newly diagnosed multiple myeloma: final analysis of the phase 3 OCTANS StudyWeijun Fu, Soo-Mee Bang, Honghui Huang, et al.
Annals of Hematology|May 23, 2025
Health-related quality of life with daratumumab, bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone alone in transplant-ineligible patients with newly diagnosed multiple myeloma: analysis of the phase 3 OCTANS studyWeijun Fu, Soo-Mee Bang, Honghui Huang, et al.
Nuclear Medicine Communications|June 1, 2016
Correlation of pretreatment 18F-FDG uptake with clinicopathological factors and prognosis in patients with newly diagnosed diffuse large B-cell lymphomaHonghui Huang, Fei Xiao, Xiaofeng Han, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 6, 2023
Bortezomib, Melphalan, and Prednisone With or Without Daratumumab in Transplant-ineligible Asian Patients With Newly Diagnosed Multiple Myeloma: The Phase 3 OCTANS StudyWeijun Fu, Soo-Mee Bang, Honghui Huang, et al.
Genome Research|December 14, 2019
Systematic genome editing of the genes on zebrafish Chromosome 1 by CRISPR/Cas9Yonghua Sun, Bo Zhang, Lingfei Luo, et al.
Pageof 9